Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 14, 2015 08:30 ET | Source: Lightbridge Corporation

Lightbridge and Canadian Nuclear Laboratories Sign Comprehensive Agreement for Fabrication of Lightbridge Nuclear Fuel Samples

MCLEAN, Va., Sept. 14, 2015 (GLOBE NEWSWIRE) -- Lightbridge Corporation (NASDAQ:LTBR), a U.S. nuclear energy company, today announced that it has signed a Comprehensive Nuclear Services Agreement...
September 09, 2015 08:38 ET | Source: Transparency Market Research

Mice Model Market expected to reach USD 1.75 Billion by 2023: Transparency Market Research

Albany - NY, Sept. 9, 2015 (GLOBE NEWSWIRE) -- According to a new market report published by Transparency Market Research "Mice Model Market - Global Industry Analysis, Size, Share, Growth, Trends and...
September 09, 2015 07:30 ET | Source: Lightbridge Corporation

Lightbridge Corporation to Present at the SeeThruEquity Fall Microcap Investor Conference in New York City

MCLEAN, Va., Sept. 09, 2015 (GLOBE NEWSWIRE) -- Lightbridge Corporation (NASDAQ:LTBR) today announced that Seth Grae, President and CEO of Lightbridge will present at the SeeThruEquity Fall...
September 08, 2015 09:00 ET | Source: Lightbridge Corporation

Aspire Capital Provides Lightbridge Corporation With Initial Funding Commitment of Up to $10 Million

MCLEAN, Va., Sept. 08, 2015 (GLOBE NEWSWIRE) -- Lightbridge Corporation (NASDAQ:LTBR) today announced that Aspire Capital Fund, LLC (“Aspire Capital”) has provided the Company with a funding...
September 01, 2015 07:05 ET | Source: Myriad Genetics, Inc.

Crescendo Bioscience Names Elena Hitraya M.D., Ph.D., as Chief Medical Officer

SALT LAKE CITY, Sept. 1, 2015 (GLOBE NEWSWIRE) -- Crescendo Bioscience, a wholly-owned subsidiary of Myriad Genetics, Inc. (Nasdaq:MYGN), announced that Elena Hitraya M.D., Ph.D., has joined the...
August 11, 2015 16:05 ET | Source: Myriad Genetics, Inc.

Myriad Genetics Reports Fiscal Fourth-Quarter and Full Year 2015 Financial Results

Total Revenues of $189.9 Million Adjusted Diluted EPS of $0.41 and Diluted EPS of $0.26 myRisk™ Hereditary Cancer Panel Ended Fourth Quarter at 72 Percent Conversion Company...
August 10, 2015 12:00 ET | Source: Ingram Micro Inc.

IBM Cloud agora disponível no Ingram Micro Cloud Marketplace

SANTA ANA, CA--(Marketwired - Aug 10, 2015) - A Ingram Micro Cloud(NYSE:: IM) anunciou hoje a disponibilidade da infraestrutura IBM Cloud no Ingram Micro Cloud Marketplace. A Ingram Micro agora...
August 03, 2015 09:27 ET | Source: Immune Therapeutics

Immune Therapeutics Inc. in partnership with GB Pharma and AHAR sign LOI with Fidson Healthcare Plc for the distribution of Lodonal in Nigeria.

ORLANDO, Florida and Dublin, Aug. 3, 2015 (GLOBE NEWSWIRE) -- via PRWEB - An agreement between Immune Therapeutics GB Pharma/AHAR with Fidson Healthcare will enable Fidson marketing, sales, customer...
July 27, 2015 08:00 ET | Source: Star Equity Holdings, Inc.

Digirad Announces That It Has Completed Its Strategic Partnership and Investment Into Perma-Fix Medical

SUWANEE, Ga., July 27, 2015 (GLOBE NEWSWIRE) -- Digirad Corporation (NASDAQ:DRAD) today announced that it has completed its previously announced strategic partnership and investment into Perma-Fix...
June 08, 2015 08:00 ET | Source: Orgenesis Inc.

Orgenesis to Present at 3rd Global Life Sciences Conference in Warsaw

GERMANTOWN, MD--(Marketwired - Jun 8, 2015) - Orgenesis Inc. (OTCQB: ORGS), a cell therapy and regenerative medicine company with a novel therapeutic technology dedicated to converting a patient's...